.Amgen has shared (PDF) the initial stage 3 records on its $400 thousand eczema drug, connecting the...
.Biogen and UCB's bet one's bottom dollar advancing into stage 3 astride a broken study aims to have...
.Italian biotech Aptadir Rehabs has launched along with the pledge that its own pipeline of preclini...
.Wave Lifestyle Sciences has fulfilled its objective in a Duchenne muscle dystrophy (DMD) research s...
.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma fold, occupying the...
.Achilles Therapies has destroyed its approach. The British biotech is actually quiting working on i...
.Aligos Therapeutics is actually advertising a midstage win in metabolic-dysfunction affiliated stea...
.Basilea Pharmaceutica's job creating brand new antifungals has acquired a substantial increase comi...
.Having actually gathered up the U.S. legal rights to Capricor Therapeutics' late-stage Duchenne mus...
.After pushing back the selection date for Applied Therapies' metabolic problem medication govoresta...